Bioventus Inc.
Ticker: 1665988
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 132.09-4.7% | 138.65-6.1% | 147.66+19.2% | 123.88-10.9% | 138.96-8.1% | 151.22+16.8% | 129.46+7.2% | 120.79 |
| Total Income | 132.09-4.7% | 138.65-6.1% | 147.66+19.2% | 123.88-10.9% | 138.96-8.1% | 151.22+16.8% | 129.46+7.2% | 120.79 |
| EXPENSES | ||||||||
| Expenditure | 123.67-2.9% | 127.40-1.5% | 129.29+8.6% | 119.01-11.8% | 134.89-25.3% | 180.59+45.5% | 124.13+4.9% | 118.38 |
| Tax | 0.57-13.6% | 0.66-36.5% | 1.04+1140.0% | -0.10-116.9% | 0.59+108.0% | -7.34-906.6% | 0.91+51.7% | 0.60 |
| PROFIT | ||||||||
| PBT | 4.52-3.2% | 4.67-54.7% | 10.31+401.5% | -3.42+29.2% | -4.83+87.8% | -39.45-676.6% | -5.08+38.0% | -8.19 |
| Net Profit | 3.11-1.6% | 3.16-57.6% | 7.46+382.6% | -2.64+45.2% | -4.82+79.9% | -23.99-424.9% | -4.57+37.4% | -7.30 |
| KEY METRICS | ||||||||
| OPM % | 6.37%-1.74pp | 8.12%-4.32pp | 12.44%+8.51pp | 3.93%+1.00pp | 2.93%+22.35pp | -19.42%-23.54pp | 4.12%+2.11pp | 2.00% |
| NPM % | 2.36%+0.08pp | 2.27%-2.78pp | 5.05%+7.18pp | -2.13%+1.34pp | -3.47%+12.39pp | -15.87%-12.34pp | -3.53%+2.52pp | -6.05% |
| EPS | 0.05+0.0% | 0.05-54.5% | 0.11+375.0% | -0.04+42.9% | -0.07+81.1% | -0.37-428.6% | -0.07+41.7% | -0.12 |
Corporate Events
Board MeetingBVS
20263Jun
Board Meeting
Election of directors and ratification of independent regist…
SEC Filing ↗